RUBICON RESEARCH LIMITED (RUBICON) Share Price rises 2.01% to Rs 1,695.25
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
RUBICON RESEARCH LIMITED Share Price is Rs 1,695.25 today, up 2.01% from the previous close, while market capitalisation stands at Rs 27,905.76 Cr. The move places RUBICON RESEARCH LIMITED Share Price among the notable gainers in Healthcare today, but according to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the stock worth tracking for what the price action and valuation say together, rather than for any unverified trigger. Univest data also shows a high-valuation setup on standard ratios, so investors monitoring RUBICON RESEARCH LIMITED Share Price can focus on the company’s financial context, the industry benchmark and how the move compares with peers. The latest Univest figures point to a stock that is rising today with no fresh narrative attached in the record.
RUBICON RESEARCH LIMITED Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,695.25 |
| Previous Close | Rs 1,661.8 |
| Today's Move | Rs 33.45 (+2.01%) |
| Open | Rs 1,661.5 |
| High | Rs 1,695.8 |
| Low | Rs 1,650.5 |
| Market Capitalisation | Rs 27,905.76 crore |
| Market Cap Category | Large Cap |
RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,695.25 from the previous close of Rs 1,661.8, a move of Rs 33.45 or 2.01%. The stock opened at Rs 1,661.5, reached a high of Rs 1,695.8, recorded a low of Rs 1,650.5.
RUBICON RESEARCH LIMITED Share Price moved higher by Rs 33.45 in intraday trade, starting at Rs 1,661.5 and last trading at Rs 1,695.25. The stock touched a high of Rs 1,695.8 and a low of Rs 1,650.5, showing a tight intraday band around the opening level.
Compared with the previous close of Rs 1,661.8, RUBICON RESEARCH LIMITED Share Price is trading above the prior session reference by 2.01%. That puts the share price rise in the context of a move that stayed near the upper end of the day’s range. For readers following RUBICON RESEARCH LIMITED Share Price Today, the main fact is simple: the stock is trading higher, the range is defined, and the move is measurable in points and percentage terms. As of 19 November 2026 at 11:22:44 AM IST, the price action remains the first signal to watch before moving into valuation and business context.
From here, the next layer is not the daily move alone but what RUBICON RESEARCH LIMITED Share Price implies relative to fundamentals and the Healthcare sector.
RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,905.76 crore |
| P/E Ratio | 84.69x |
| P/B Ratio | 19.42x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 19.62 |
| Book Value Per Share | Rs 85.56 |
| Dividend Yield | 0.09% |
RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P/E 84.69x, P/B 19.42x, ROE 27.84%, ROCE 29.22%. These ratios show where the company stands today and are not a call to buy or sell.
RUBICON RESEARCH LIMITED has a market capitalisation of Rs 27,905.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.69x, P/B at 19.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 19.62, book value per share of Rs 85.56, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.6x, median ROE of 11.23%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 84.69x |
| Benchmark Median P/E | 30.6x |
| Benchmark Average P/E | 59.27x |
| Benchmark P/E Range | 2.71x to 1,378.1x |
| Company P/B Ratio | 19.42x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 27,905.76 crore |
| Benchmark Median Market Cap | Rs 789.58 crore |
RUBICON RESEARCH LIMITED (RUBICON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 84.69x, which is above the benchmark median of 30.6x, a difference of +176.76%. A P/E difference of this kind is a reference point rather than a recommendation.
RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.23%, a difference of +147.91%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.1%, a difference of +123.05%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,687.64 | 40.96 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,95,080.27 | 87.38 | 16.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,677.43 | 83.06 | 9.6 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,26,433.06 | 93.64 | 20.7 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,969.79 | 28.52 | 4.29 | 19.69 | 21.39 |
RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 84.69x compared with the displayed peer median of 83.06x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 27,905.76 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching RUBICON RESEARCH LIMITED
- RUBICON RESEARCH LIMITED Share Price is trading higher by 2.01% at Rs 1,695.25, so the day’s price action itself is a focus point.
- The company carries a market capitalisation of Rs 27,905.76 Cr, which keeps RUBICON RESEARCH LIMITED Share Price relevant in Healthcare coverage.
- RUBICON RESEARCH LIMITED Fundamental Analysis shows ROE of 27.84% and ROCE of 29.22%, both strong against the industry benchmark.
- The P/E of 84.69 and P/B of 19.42 keep valuation central to RUBICON RESEARCH LIMITED Share News and stock analysis.
- Peer comparison shows stronger profitability ratios than several listed peers, which supports why RUBICON RESEARCH LIMITED Share Price stays in market focus.
About RUBICON RESEARCH LIMITED
RUBICON RESEARCH LIMITED operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s market positioning is reflected in its market capitalisation of Rs 27,905.76 Cr and its valuation profile on the listed market. For readers tracking RUBICON RESEARCH LIMITED Share Price, the company belongs to a segment where profitability, pricing power and long-term execution often matter more than a simple daily move.
The key business context available here is sector and industry placement, supported by financial ratios that show strong return metrics. RUBICON RESEARCH LIMITED Share Price therefore reflects both a large listed footprint and a premium valuation framework. For investors studying RUBICON RESEARCH LIMITED Company News, the main takeaway is that the stock sits within a widely followed pharmaceuticals universe, where valuation comparisons with peers remain highly relevant.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is RUBICON RESEARCH LIMITED Share Price rising today?
Ans. RUBICON RESEARCH LIMITED Share Price is rising by 2.01% today to Rs 1,695.25. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is RUBICON RESEARCH LIMITED Share Price today?
Ans. RUBICON RESEARCH LIMITED Share Price is Rs 1,695.25, up Rs 33.45 from the previous close of Rs 1,661.8. The move keeps the stock in intraday focus. The stock moved 2.01% so far today.
What is the market capitalisation of RUBICON RESEARCH LIMITED?
Ans. RUBICON RESEARCH LIMITED has a market capitalisation of Rs 27,905.76 Cr. That places RUBICON RESEARCH LIMITED Share Price in a large listed value range within Healthcare. The company operates in the Healthcare sector.
How does RUBICON RESEARCH LIMITED compare on valuation?
Ans. RUBICON RESEARCH LIMITED Share Price carries a P/E of 84.69 and P/B of 19.42. Both are above the same-industry median and average, which keeps valuation central to the discussion.
What do ROE and ROCE show for RUBICON RESEARCH LIMITED?
Ans. RUBICON RESEARCH LIMITED reports ROE of 27.84% and ROCE of 29.22%. Those ratios are above the industry median and average, adding context to RUBICON RESEARCH LIMITED Share Price.
How does RUBICON RESEARCH LIMITED compare with peers?
Ans. RUBICON RESEARCH LIMITED Share Price has stronger ROE and ROCE than the peer set listed here, while its P/E is higher than several peers and lower than a few others in the same industry.
What are the key fundamental numbers for RUBICON RESEARCH LIMITED?
Ans. RUBICON RESEARCH LIMITED Share Price is backed by EPS of 19.62, book value of Rs 85.56 and dividend yield of 0.09%. These figures help frame the valuation view.
Which sector and industry does RUBICON RESEARCH LIMITED belong to?
Ans. RUBICON RESEARCH LIMITED belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context is essential when reading RUBICON RESEARCH LIMITED Share Price and its peer valuation.
Track RUBICON RESEARCH LIMITED Share Price on Univest
Use RUBICON RESEARCH LIMITED (RUBICON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track RUBICON RESEARCH LIMITED Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights. Univest also helps place RUBICON RESEARCH LIMITED Share Price in context through sector benchmarks, peer comparison and financial analysis. For users following RUBICON RESEARCH LIMITED Share Price Today, that combination keeps the daily move connected to the broader stock story.